赛升药业：公司聚焦增收、降本、提效推进经营

Core Viewpoint - The company is focusing on increasing revenue, reducing costs, and improving efficiency to enhance capital utilization and profitability while strategically planning for future project investments [1] Group 1: Strategic Development - The company has established a group development layout based on five strategic platforms: R&D innovation platform, pharmaceutical industry chain innovation platform (including high-end formulations and oral formulations production bases, active pharmaceutical ingredient production base, and modern Chinese medicine production base), collaborative technology innovation platform, capital industry platform, and seed industry innovation platform [1]